Moderna, Inc.
MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30573% above fair value
$220.83−0.89 (-0.40%)
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Computer equipment and software, gross by Quarter
Computer equipment and software, gross ($M) ($M)
Moderna Computer equipment and software, gross: $205M in Q2 2026, up 27.3% from a year earlier. That is the highest of the 30 quarters on record here.
Latest, Q2 2026
205
Period ended Jun 30, 2026
Change on a year earlier
+27.3%
161 in Q2 2025
History
30 quarters
Since Q4 2018
Sources
29
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-07-31) ↗
Reported in Form 10-Q / 10-K Note 8 (Balance Sheet Details).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Moderna Computer equipment and software, gross ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ppe-gross-computer
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.